-- 周四,受本周天然气库存大幅增加以及相对利好的天气预报提振,美国天然气期货价格上涨。 近月亨利枢纽天然气期货合约和连续基准价格均上涨0.84%,收于每百万英热单位2.63美元。 此前,美国能源信息署(EIA)将于周四发布每周天然气库存报告。据Investing.com汇编的数据显示,预计本周天然气库存净增550亿立方英尺(Bcf),高于上周的500亿立方英尺和去年同期的160亿立方英尺。 与此同时,NRG Energy的数据显示,发电用天然气需求增加50亿立方英尺,但被居民和商业用气需求下降50亿立方英尺所抵消。 这主要是由于近几周天气较为温和,导致天然气供暖需求下降,因为美国大部分地区的气温高于往年同期水平。 然而,天气预报此后变得相对乐观,据美国国家气象局称,只有南部和东南部部分地区的气温将高于正常水平,而西南部和东北部地区预计在 4 月 23 日至 4 月 29 日期间气温将低于正常水平。
Related Articles
Oneview Healthcare Reports Decline in Q1 Cash Receipts From Customers; Shares Up 3%
Oneview Healthcare (ASX:ONE) reported cash receipts from customers of about 3.3 million euros for the first quarter, compared with 4.2 million euros a year earlier, according to a Monday filing with the Australian bourse.The company noted that the year-ago figure includes two large customer receipts totaling more than 2 million euros, which were due to be received during the fourth quarter of 2024 but were received in early 2025.Oneview Healthcare ended March with a cash balance of AU$17.1 million, up from AU$8.1 million at the close of 2025, per the filing.The company's shares gained 3% in recent Monday trade.
Paradigm to Advance Participants Through Day 112 Follow-Up Period in Phase Three Knee Osteoarthritis Trial, Shares Reach One-Year Low
Paradigm Biopharmaceuticals (ASX:PAR) is set to progress participants through the day 112 follow-up period for the phase three trial evaluating injectable pentosan polysulfate sodium for the treatment of pain associated with knee osteoarthritis in the June quarter, which is required for inclusion in the interim analysis dataset, according to a Monday Australian bourse filing.The independent statistical analysis results for the data set are expected around August. Timing remains subject to the scheduling and review processes of independent third parties, and there is a reasonable likelihood that final interim outcomes may extend into September, it cautioned.The interim analysis is expected to provide the first phase three evaluation of efficacy and safety for injectable pentosan polysulfate sodium in knee osteoarthritis. Primary endpoint top-line results are expected in the March 2027 quarter.Its shares fell 14% in recent trading on Monday, reaching their lowest point in over a year.
Sanan Optoelectronics Q1 Profit Down 68%, Revenue Slides 33%
Sanan Optoelectronics (SHA:600703) posted first-quarter attributable net profit of 67.5 million yuan, down 68% from 211.9 million yuan the previous year.Earnings per share declined to 0.01 yuan from 0.04 yuan, according to a weekend filing with the Shanghai bourse.Operating revenue declined 33% year over year to 2.91 billion yuan from 4.31 billion yuan.Shares of the software company declined 2% in recent trade.